October 21, 2023

Joint KDA-IAS Session at 2023 ICDM

Host: International Congress of Diabetes and Metabolism

Gyeongju, South Korea

Endorsed Activity
Go to event website

In this session, speakers will discuss many important topics of anti-diabetic treatment and cardiovascular diseases:

  • Update of KDA guidelines focused on SGLT 2 inhibitor and GLP1 therapy
  • SGLT2 inhibitor and CVOTs
  • GLP 1-based therapy and its effect on CVDs
  • Recent update of familial hypercholestrolemia treatment.

Promoting the scientific understanding of atherosclerosis

Newsletters

Stay in touch with IAS